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1. Introduction 
Kidney grafts begin normal function immediately after transplantation, after several, or after 
dozen or so days delay. Acute Kidney Insufficience (AKI), Nephrotic Syndrome (NS) and 
Chronic Allograft Nephropathy (CAN), sometimes defined as “Interstitial Fibrosis / 
Tubular Atrophy (IF/TA) without any specific etiology” (Reuter et al., 2010), are the main 
types of complications connected with kidney transplantation. 
In the diagnosis of the function of transplanted renal allografts, activities of enzymes 
excreted into urine by particular fragments of nephron are used. Increase of enzymuria 
precedes some clinical symptoms and is a more sensitive diagnostic marker than tubular 
proteinuria. Increase of enzymuria may also be useful for determination the time since renal 
tubules damage took place. Fructose-1,6 – bisphosphatase (FBP-1,6)- the principal enzyme of 
gluconeogenesis and N-acetyl-ǃ-hexosaminidase (HEX)- the most active of the lysosomal 
exoglycosidases, taking part in the degradation of glycoconjugates (glycoproteins, 
glycolipids, proteoglycans), are markers used for monitoring kidney allograft function both 
in early and late post transplant periods, because of localization in the proximal contorted 
and straight tubules of nephron.  
2. Urinary fructose-1,6-bisphosphatase (FBP-1,6) key enzyme of 
gluconogenesis  
2.1 Renal glucose production 
Kidneys require a continuous supply of glucose as a metabolic fuel. In the absence of dietary 
intake of carbohydrates, glycogen stores (mostly liver’s) are able to supply glucose for only 
ten to eighteen hours. Fortunately liver and kidneys are able to produce glucose via the 
gluconeogenesis pathway (Champe et al., 2008) [Fig. 1.].  
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Fig. 1. Renal gluconeogenesis. The key enzymes of gluconeogenesis: (1) Pyruvate 
Carboxylase (PC), (2) PhosphoEnol Pyruvate CarboxyKinase (PEPCK), (3) Fructose-1,6-
BisPhosphatase (FBP-1,6), (4) glucose-6-phosphatase. The main renal gluconeogenic 
substrates are: glutamine, lactate, glycerol. 
Renal glucose production accounts for between 5% to 25% of the total glucose formed by 
gluconeogenesis, in the body (Conjard et al., 2001; Meyer et al., 2003). The proximal renal 
tubules are capable of synthesizing glucose from a variety of precursors, including lactate, 
pyruvate, glutamine (the main substrate of renal gluconeogenesis), glutamate, and glycerol. 
The three segments of the renal proximal tubules PCT1, PCT2 and PST [Fig. 2.] can 
synthesize glucose at different rates from lactate. PCT2 and PST segments synthesize more 
glucose from lactate than the PCT1 segment (Yáñez et al., 2003; Yáñez et al., 2005). The PCT1 
segment is specialized in the reabsorption of lactate in kidney (Yáñez et al., 2005). The 
segments PCT1, PCT2 and PST synthesize glucose from glutamine with about the same 
certain amino acids (glutamine)  
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capacity (Conjard et al., 2001), which indicates that glutamine is the main gluconeogenic 
substrate for the kidney (Stumvoll et al., 1997). Also fructose, propionate and proline are 
potential candidates for renal glucose precursors (Conjard et al., 2001; Meyer et al., 2003; 
Stumvoll et al., 1997). Fructose-1,6-bisphosphatase (FBP-1,6. EC 3.1.3.11) [Fig. 1.] is a key 
regulatory enzyme for renal gluconeogenesis. 
 
 
Fig. 2. Localization of FBP-1,6 and HEX in the nephron.  FBP -1,6  is confined to the Proximal 
Convoluted Tubule –PCT1, PCT2 and Proximal Straight Tubule –PST. Lysosomal N-acetyl-
ǃ-D-hexosaminidase (HEX) is distributed along the nephron with highest activity in the 
proximal convoluted tubule PCT1 and PCT2. 
2.2 Structure and action of kidney FBP-1,6 
FBP-1,6 catalyzes the irreversible conversion of fructose-1,6-bisphosphate (Fru-1,6-P2) to 
fructose-6-phosphate and inorganic phosphate in the reaction: 
Fructose 1,6-bisphosphate + H20 = Fructose-6-phosphate + phosphate  
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The mammalian kidney FBP-1,6 is a tetramer composed of four identical subunits with  
molecular weight ranging from 36 kDa to 41 kDa per subunit (e.g. each subunit of the pig 
kidney enzyme consists of 337 amino acids), organized as a dimer of dimers [Fig. 3.].  
 
 
Fig. 3. The quaternary structure of fructose-1,6-bisphosphatase (R-state). The four subunits 
of FBP-1,6 are designated S1,S2,S3,S4 and are labeled clockwise. The S1 and S2 subunits 
correspond to the upper dimer, and the S3, S4 subunits correspond to the lower dimer. Each 
subunit is composed of two folding domains. The AMP domain has the AMP binding site 
(▲), while the Fru-1,6-P2 (Fbp) domain contains the active site (●). The divalent metal sites 
(■) are located between the AMP and Fbp domains. Residues of the 190’s loop make critical 
contacts with Lys-42 (K42). The R→T transition of FBP-1,6 involves a 15°-17° clockwise  
rotation of the S1:S2 dimer in respect to the S3:S4 dimer. 
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The tetramer of FBP-1,6 requires divalent cations: magnesium, manganese, zinc or cobalt for 
its catalytic activity (Dżugaj, 2006; Sáez et al., 1996; Yáñez et al., 2003). In each of four (S1, S2, 
S3 and S4) subunits, X-ray crystallographic studies have identified that the AMP and FBP 
domains [Fig. 3.]. Fru-1,6-P2 (substrate) binding site (●) is located in each of four FBP 
domains. The AMP-binding sites (▲) are located at AMP domains approximately 30Å from 
the active site. One divalent metal-binding site (■) is located at each of the FBP domain 
between the Fru-1,6 P2 and AMP binding domains of each subunit [Fig. 3.]. Pig kidney FBP-
1,6 exists in at least two quaternary conformations called R (relaxed)-active, and T (tense)- 
inactive state, depending on the relative concentrations of the FBP-1,6  effectors. The 
allosteric transition R→ T of kidney FBP-1,6  involves a 150-170 clock-wise rotation around 
the vertical axis of the S1:S2 (upper) dimer, with respect to the S3:S4 (lower) dimer (Kelly et 
al., 1996; Lu et al., 1996; Zhang et al., 1994) [Fig. 3.]. Localization the 190’s loops and Lys-42 
near the horizontal and vertical molecular symmetry axes is critical for the R→T transition. 
AMP (reflecting shortage of energy) inhibits the enzyme, shifting FBP-1,6 from the R to the T 
conformation [Fig. 3.]. In the absence of AMP the FBP-1,6 exists in the active R state. 
Fructose-1,6-bisphosphate, fructose-6-phosphate and ATP (reflecting excess of energy), as 
well as metal cations, stabilize the R (active) state (Kelly-Loughane & Kantrowitz, 2001; 
McIninch & Kantrowitz, 2001). Mammalian kidney FBP-1,6 is activated by high 
glucagon/insulin ratio, which elevate cAMP level and increase activity of protein kinase A. 
Increased activity of protein kinase A favors the phosphorylation of bifunctional complex 6-
phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Phosphorylated phosphofructokinse-2 
is inactive, which decreases the level of fructose 2,6-P2 (inhibitor of FBP-1,6) (Champe et al., 
2008). FBP-1,6 has two synergistic natural inhibitors: mentioned earlier adenosine-5’-
monophosphate (AMP), and fru-2,6-P2, a product of the bifunctional phosphofructokinase-
2/ fructose bisphosphatase-2 (Hines et al., 2007; Sáez et al., 1996; Wu et al., 2006). Excess of 
FBP-1,6 substrate i.e Fru-1,6-P2, acts as an inhibitor on FBP-1,6. Are novel inhibitors of 
fructose-1,6-bisphosphatase such as achyrofuran, anilinoquinazoline (also an inhibitor of 
tyrosine kinase) and 3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid (MDL-
29951)- also an antagonist of the glycine site of the NMDA receptor (Wright et al., 2001; 
Wright et al., 2003).  
2.3 Ultrastructural localization of the FBP-1,6 in kidney 
FBP-1,6 immunoreactivity was detected in kidney cortex cells, but not in the medulla. In the 
cortex all epithelial cells the PCT1, PCT2, and PST segments, forming the proximal 
convoluted tubules were FBP-1,6 positive (Yáñez et al., 2003). Aldolase B, but not aldolase 
A, colocalizes and forms a complex with FBP-1,6 (Yáñez et al., 2005).  
Expression FBP-1,6 activity in cytoplasm and apical cells membranes  PCT1, PCT2 and PST 
segments of  the proximal tubules was demonstrated (Yáñez et al., 2003) [Fig. 2.]. Expression 
of FBP-1,6 was also observed in the basolateral membrane region of the PCT1 segment of the 
proximal tubule and colocalized with the MonoCarboxilate Transporter 1 (MCT1) (Yáñez et 
al., 2003; Yáñez et al., 2005). MCT1 contributes to the transport of monocarboxylic acids in 
many tissues, which suggest that the PCT1 segment is specialized in the reabsorpion of 
lactate in kidney. The actual level of lactate transporter expression in the PCT1 segment 
might be the reason for the difference in the rates of glucose neosynthesis from lactate in the 
human renal proximal tubules (Yáñez et al., 2003).  
The subcellular location of kidney FBP-1,6 is similar to liver FBP-1,6. The histochemical 
analysis revealed that the anti-FBP-1,6 antibody detected two single bands with a molecular 
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weight of 36kDa and 40 kDa, in kidney and liver, respectively (Yáñez et al., 2003). The 
immunofluorescence and confocal analysis revealed that FBP-1,6 was present in the cytosol 
and inside the nucleus of hepatocytes and proximal cells of the nephron (Sáez et al., 1996). 
Nuclear FBP-1,6 function is similar to the function of the cytosolic form. FBP-1,6  can be 
translocated inside the nuclei of proximal tubule cells (Yáñez et al., 2003; Yáñez et al., 2005). 
The peroxidase reaction in light microscopy, yielded a strong signal FBP-1,6 in the proximal 
straight and convoluted tubules located at the cortex, but not in cells of the kidney medulla. 
The FBP-1,6 reaction is concentrated in the apical membrane region and is also observed in 
the basolateral membrane region (Yáñez et al., 2005). No immunoreactivity was observed in 
glomeruli, ascending and descending loops of Henle, collecting tubules, distal tubules and 
in cell of the kidney medulla (Sáez et al., 1996; Yáñez et al., 2003). 
Determination of the fructose-1,6-bisphosphatase activities in the fractions of kidney and 
liver (assayed spectrophotometrically at 300C, by following the rate of NADH formation) 
revealed that FBP-1,6 activity is present in both tissues in the initial homogenate, the 
cytoplasmic extract and the high speed  supernatant. No activity of FBP-1,6 was observed in 
the nuclear fraction, light or the heavy mitochondrial and microsomal fraction (Sáez et al., 
1996). 
2.4 Genetics and localization of the FBP-1,6 isozymes in human tissues 
Human FBP-1,6 is coded in 2 distinct genes, FBP1 and FBP2 (Matsuura et al., 2002). FBP1 
consist of seven exons and spans over 31 kilobases at chromosome 9q22.2-q22.3 and 
expresses a 362-amino acid (el-Maghrabi et al., 1995). Messenger RNA (mRNA) from liver, 
kidney and monocytes is identical (Kikawa et al., 1994). FBP2 which was isolated from 
muscle, codes 339 amino acids, and shares 77% amino acid sequences identity with FBP1 
(Tillmann & Eschrich, 1998). 
FBP-1,6 is expressed in variety of organs such as: liver, kidney, muscle,  brain, lung, small 
intestine, retina (Cloix et al., 1997; Mamczur et al., 2010; Nomura et al., 1994; Velásquez et 
al., 2010; Yáñez et al., 2003; Yáñez et al., 2005). Existence of four isozymes: muscle, liver, 
brain and intestine in tissues of vertebrates has been postulated (Dżugaj, 2006). In mammals 
two isoforms of FBP-1,6 exist, which are encoded by separate genes. In humans L-FBP-1,6 
which is expressed mainly in liver and kidney, and M-FBP-1,6 is expressed mainly in 
muscle. Both isforms ( L-FBP-1,6 and M-FBP-1,6) were found in several organs such as lung 
and brain (Bigl et al., 2008). 
3. FBP-1,6 in kidney transplantation 
After damage of the epithelial cell membranes, FBP-1,6 is released into urine. Therefore 
urinary FBP-1,6 activity was recommended for diagnoses of complications in the early post- 
transplantation period. Urinary FBP-1,6 was assayed in the second morning midstream 
urine portion in patients after transplantation. Cold ischemia time was 20.6±8.4h (range 3-
32h), with a median of 22 h. Urinary FBP-1,6 excretion was significantly lower in grafts 
stored for a shorter time than 22 hours (0.69±0.42 U/g creatinine) as compared to FBP-1,6 
urinary excretion in grafts stored > 22 hours (1.13±0.56 p=0.035 U/g creatinine). Multiple 
regression analysis demonstrated that the cold ischemia time was the only pre-transplant 
factor, which significantly correlated with early post-transplant urinary FBP-1,6 excretion 
(multiple R=0.65, F=14.6, p<0.001). After transplantation the patients were given 
cyclosporine A (CsA), but CsA levels did not correlate with urinary FBP-1,6 activities during 
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the first four postoperative days. The duration of the cold ischemia time is significantly 
correlated with the degree of urinary excretion of FBP-1,6 during the first four postoperative 
days (Kotanko et al., 1997). 
Sharp increase in the activities of lactate dehydrogenase (LDH), glucose-6-phosphatase 
(G6Pase), malic enzyme (ME) and fructose-1,6-bisphosphatase (FBP-1,6) was observed in 
homogenates of renal cortex and medulla, after 5 min of warm ischemia induced by 
occlusion of rat renal left artery. Warm ischemia lasting 15-60 min resulted in a progressive 
decrease in the activity of the above enzymes. Reperfusion of rat kidneys for 60 min after 
prolonged warm ischemia caused complete recovery of the activity of the above enzymes 
(Khundmiri et al., 2004).  
Five to ten day after uncomplicated renal transplantation enzymuria reaches a constant 
value, which is much higher than the average in healthy humans (Jung et al., 1992). Activity 
of urinary FBP-1,6 reached a lower level on the 4th day after transplantation, and remained  
on a stable low rate. During the four first days after transplantation the activity of urinary 
FBP-1,6 amounted to 0.9±0.5 U/g (0.1±0.06 U/mmol urinary creatinine); range 0.2-2.1 U/g 
(0.02-0.24 U/mmol)] (Kotanko et al., 1997). However in complicated transplantations 
urinary excretion of FBP-1,6 significantly increases, contrary to urinary creatinine 
concentration, which change slowly (Jung et al., 1992).  
During experimental transplantation renal grafts taken from non-heart beating donors, 
fructose- 1,6-bisphosphate was used, for protection graft microcirculation against ischemic 
damage. Microdialysis probes in the renal cortex of pig kidney were used to monitor 
pyruvate concentration during hypotermic machine perfusion with a perfusate containing 
29.4 mM exogenous fructose-1,6-diphosphate (FDP). During glycolysis fructose-1,6-
diphosphate (FDP) is generated from glucose and is transformated into pyruvate. In the 
absence of oxygen, pyruvate is transformated into lactate rather than acetyl-CoA and is 
accumulated in the cell. The decrease of pH inhibits glucose conversion to fructose-1,6-
diphosphate. Significant increases in pyruvate production (p<0.05) were observed after 12h 
of perfusion in the interstitial fluid of FDP-treated kidneys, as compared to control kidneys. 
After 24 h of graft perfusion the concentration of pyruvate was 149.1±58.4 µM in the FDP 
group and 55.6±17.9µM in the control group. The addition of FDP to the fluid during 
ischemic kidney perfusion, resulted in enhanced pyruvate production in the extracellular 
space. FDP has rheologic and antioxidant effects in addition to its ability to promote 
glycolysis and improve red blood cell deformability (Baicu et al., 2004).  
FDP prevents the decline of renal cortical Na-K-ATPase activity induced by ischemia end 
gentamicin toxicity. Lu and Lin (Lu & Lin, 1989) have shown that fructose-1,6-diphosphate 
(FDP) has the ability to restrain the oxygen-radical related reperfusion injury.  They 
observed reduction in renal Na-K-ATPase activity by 18.6% after 30 min of renal pedicle 
clamping and 60 min of reflow as well as a 32.5% reduction in renal Na-K-ATPase activity 
after 90 min of injection 100mg/kg gentamicin. Application of 4g/kg fructose-1,6-
diphosphate (FDP) and 60 min infusion after reflow in the ischemic group, and 90 min 
infusion after injection of the drug in gentamicine-treated group, increased renal Na-K-
ATPase activity in the FDP-treated group in comparison to the control kidney (Lu & Lin, 
1989).  
Expression of urinary FBP-1,6 protein is utilized to evaluate the degree of chronic post 
transplant nephropathy. Increased expression key renal enzymes of the citrate circle i.e. 
NAD+-dependent Isocitrate DeHydrogenase (IDH) and Iron-Responsive Element-Binding 
Protein-1/aconitase (IREBP1), as well as mitochondrial CK, creatine kinase B-type, ornithine 
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aminotransferase and FBP-1,6 were observed in IF/TA. FBP-1,6 protein was expressed at a  
significantly lower level in aTX(allogenic graft) than in sTX (syngenic graft) (Reuter et al., 
2010). The above data is supported by analysis of gene expression profiles of renal 
transplants, which revealed reduced FBP-1,6 mRNA level in graft with IF/TA (Scherer et al., 
2003). 
Determination of urinary FBP-1,6 activity was not only used for evaluation of transplanted 
kidneys, but also to estimate the degree of damage to renal tubules of diabetic patients (Eid 
et al., 2006), in idiopatic nephrotic syndrome (Kępka et al., 2008) acute pyelonephritis (Zoch-
Zwierz et al., 2004), heavy metal (e.g.HgCl2) or, maleic acid intoxication (Kotanko et al., 
1984), after trichloroethylene (TCE) administration (Khan et al., 2009). The urinary FBP-1,6 
activity significantly increases after nephrotoxic drugs (ifosfamide, cisplatinum) (Pfaller et 
al., 1994) prednisolone, and azathioprine (Kotanko et al., 1986), cyclosporine, sirolimus and 
tacrolimus (Klawitter et al.,2010). 
4. HEX - most active exoglycosidase in catabolism of   glycoconjugates 
All renal glycoconjugates (glycoproteins and glycolipids, present in renal cell membranes, 
and participating in inter cellular communication and interactions, as well as 
glycosaminoglycans of the renal cell surfaces, and extra cellular matrix), contain 
oligosaccharide chains (Gabius, 2009).Glycoconjugates are subject to constant synthesis and 
degradation. The protein cores of the glycoconjugates are synthesized in the cytoplasm, but 
glycosylation occurs in endoplasmatic reticulum and Golgi Apparatus (Zwierz et al., 1999). 
Lysosomes are the principal sites of intracellular digestion of sugar chains of 
glycoconjugates (Cuervo, 2004). Exoglycosidases which successively release individual 
sugars from non reducing ends of oligosaccharide chains are localized in lysosomes 
(Strecker et al., 1988; Winchester, 2005) [Fig. 4].  
N–acetyl-ǃ-hexosaminidase (HEX) (EC 3.2.1.52) is the most active of lysosomal 
exoglycosidases (Popko et al., 2008), taking part in the catabolism of oligosaccharide chains 
of all types of glycoconjugates (Zwierz et al., 1999). The fact that HEX has the highest 
activity of amongst exoglycosidases may be explained by the fact that aminohexoses (N-
acetyl-glucosamine and N-acetyl-galactosamine) are components of all types of 
glycoconjugates: glycoproteins, glycolipids and glycosaminoglycans of proteoglycans 
(Chojnowska et al., 2011). HEX releases monomers of N-acetyl-glucosamine and N-acetyl-
galactosamine from the non reducing ends of oligosaccharide chains of glycoconjugates 
(Zwierz et al., 1999). Isoenzymes of HEX are composed of two polypeptide chains (ǂ and ǃ) 
which are products of gene duplication (Pennybacker et al., 1996). Of the heat labile 
isoenzymes S (ǂǂ) and A (ǂ,ǃ), heat stable isoenzyme B (ǃǃ) (Pérez & Tutor, 1998) and P 
(ǃǃ) (Arciuch et al., 1999), HEX A and HEX B are the most common. In the majority of 
tissues  HEX A (MW 96-110 kDa) and HEX B (MW 100-110 kDa) have similar contribution to 
the total HEX activity, because in normal conditions HEX S has only trace activity  (Zwierz 
et al., 1999), and HEX P appears only in several situations e.g. pregnancy (Arciuch et al., 
1999). 
Kidneys are a rich source of HEX (Borzym-Kluczyk et al., 2005). HEX activity in the nephron 
is highest in proximal convoluted tubules. In proximal convoluted tubules HEX activity is 
three times higher than in renal corpuscles (Jung et al., 1992). HEX A and HEX B with the 
distinct dominance of HEX A are present in renal medulla and renal cortex (Tassi et al., 
2000). In the urine of healthy humans the activity of HEX is low, mainly due to HEX A 
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derived from naturally exfoliated proximal convoluted tubule cells. Urinary excretion of 
HEX depends on age, sex, race and blood pressure (Agirbasli et al., 1996). Although HEX is 
present in variety of tissues and body fluids, urinary HEX activity is the most significant 
(Ostrowska et al., 1993). 
 
 
Fig. 4. Catabolism of the sugar chains of N-linked glycoproteins. 
Asn- asparagine,Gal-galactose, GlcNAc-N-acetylglucosamine,Fuc-fucose, Man- mannose, 
SIA – Sialic acid (N-acetylneuraminic acid). 
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Urinary HEX activity is independent of diuria, diurial variations, low pH, or presence of the 
morphotic elements of blood (Costigan et al., 1996). Urinary HEX activity increases from 
several to dozens of times after damage to the epithelium of proximal convoluted tubules 
cells (Rustom et al., 1998). As cells of renal proximal convoluted tubules are very sensitive to 
hypoxia, all pathological states occurring with hypoxia, lead to dysfunction of the 
epithelium of renal proximal convoluted tubules, and leakage of HEX into urine (Chujo et 
al., 2008). The kidneys are critical targets for toxicity induced by heavy metals e.g. cadmium 
(Jung et al., 1993), and HEX activity in urine is recommended as a simple, stable, and cheap, 
screening indicator for early detection of renal dysfunction caused by cadmium (Jung et al., 
1993). 
5. HEX in renal transplantation 
HEX was used for evaluation of the condition of human kidney grafts before 
transplantation, condition of transplanted kidneys, and estimation of toxicity of drugs used 
during renal transplantation. 
In evaluating the contribution of the Na+/H+ antiporter of kidney donors and recipients to 
post reperfusion injury and recovery after transplantation, HEX urinary excretion rate was 
treated as independent predictor. Positive association of donor antiport activity with total 
HEX excreted within the first three days after transplantation reflecting acute post perfusion 
injury, confirmed antiport active contribution to renal susceptibility to the ischemic insult. 
Urinary HEX excretion was treated as one of the independent predictors of short-term graft 
outcome, and the length of the recipient’s stay at hospital (Matteucci et al., 1999). Excretion 
into urine of trimethylamine-N-oxide (TMAO) - derived from renal medullary osmolytes, 
and metabolites of glycolysis (lactate) or Krebs cycle (acetate, citrate) (reflecting energy 
supply to the cells) was used for the evaluation of the influence of retrieval conditions (cold 
storage and reperfusion) on renal medulla injury in an isolated perfused pig kidney model. 
Determination of the above substances by proton NMR spectroscopy as early markers of 
ischemia reperfusion injury during cold storage and reperfusion, is a proof that increase in 
TMAO and metabolites of glycolysis or Krebs cycle are relevant markers of graft damage 
during cold storage and reperfusion. In the model above HEX was not efficient in assessing 
tubular damage during cold storage and reperfusion, which may be explained by the fact 
that increase in TMAO and disregulation of glycolysis and Krebs cycle precede any increase 
in excretion of HEX connected with damage of cell, and leakage of lysosomal enzymes 
taking part in the degradation of damaged tissues (Hauet et al., 2000). Working on the same 
model it was stated that TMAO (trimethylamine-N-oxide), DMA (dimethylamine) and 
acetate are more efficient parameters for assessing the impact of preservation solutions on 
renal medulla injury than HEX (Hauet et al., 2000). 
HEX activity is an established biomarker for assessing the condition of machine perfused 
kidneys for transplantation, and for predicting kidney transplant outcome. Out of six 
biomarkers evaluated (Lactate DeHydrogenase-LDH, ASpartate AminoTransferase-
ASAT, Glutathione –S-Transferase-GST, HEX, Heart type Fatty Acid Binding Protein-H-
FABP), ROC analysis certifies that only three of them (GST-AUC 0.67, HEX-AUC 0.64, H-
FABP-AUC 0.64) measured in machine perfusion perfusate at the end of machine 
perfusion, are independently associated with the risk of delayed graft failure (Moers et al., 
2010). Therefore it was concluded that GST, HEX and H-FABP are independent predictors 
for delayed graft failure, but not the graft survival. Increased activity of GST, HEX and H-
www.intechopen.com
Urinary fructose-1,6-Bisphosphate (FBP-1,6)  
and N-Acetyl-β-Hexosaminidase (HEX) in Monitoring Kidney Transplantation - Literature Review 
 
99 
FABP in the machine perfusate could be an additional factor to consider in adjusting 
postoperative recipient management, but not in the decision to transplant or discard 
kidneys donated after brain death (Moers et al., 2010). Urinary excretion of the HEX 
activity (determined by fluorometric method) was used for the evaluation of the influence 
of long-term blood pressure and renal function in kidney donors, and of renal tubular 
function after transplantation. Excretion of HEX was positively correlated with the 
excretion of total protein, albumin and ǃ2 – microglobulin (p= 0.000, p<0.007, and p= 
0.002, respectively) (Talseth et al., 1986). Renal allograft function during the first 24 h after 
transplantation was compared with the function of remaining second kidney of the living 
donor in the first hour after transplantation. A 4-fold (significantly) higher level of HEX 
excretion in the recipients compared with the donors, falling to 2–fold (significantly) 
higher level after 6 hours, and only tendening to increase after 24 h after transplantation, 
was observed (Bugge et al., 1999). HEX is a specific indicator of ischemia/reperfusion 
injury of proximal tubules and attenuation of this injury by atrial natriuretic peptide 
(Chujo et al., 2008). During rejection in 92% of renal allografts, a significant increase in 
total HEX activity, and decrease in urinary activity of HEX A, with simultaneous increase 
in activity of HEX B, and intermediary forms of HEX, was observed (Whiting et al., 1983). 
Urines from transplant patients showed HEX isoenzyme patterns similar to the normal 
urine, but in episodes of rejection, dependent on the degree on severity of rejection, total 
HEX activity increased. Increase in total HEX activity was caused by intermediate forms 
which increased more than 10-fold, however with a simultaneous decrease in activity of 
HEX A and HEX B (Kind, 1982). 
Two mathematical models: model A based on excretion of one, and the model B based on 
excretion of four enzymes were used for evaluation of the applicability of urinary excretion 
of Fructose-1,6-BisPhosphatase (FBP-1,6), Glutathione S-Transferase (GST), HEX and 
Pyruvate Kinase (PK), in renal allograft of patients after transplantation, who were given 
cyclosporin A (CyA group)  or azathioprine and prednisolone (CON-group). In excretion of 
one enzyme (model A) the best results were obtained in the CON-group, using GST or 
FBP-1,6 urinary activities. Urinary HEX and PK were less efficient than GST and FBP-1,6. In 
the CyA group, FBP-1,6 or GST recognized 7 out of 9 graft rejections; PK diagnosed 5, but 
HEX only 4 rejections. In the CON-group, using model B, four of the above urinary activities 
were sufficient to detect all 12 graft rejections. FBP-1,6 was the best individual marker 
enzyme, followed by HEX. The combinations HEX/PK/GST and HEX/GST sufficed to 
detect all 12 rejections in the CON group, but only one in the CyA group (Kotanko et al., 
1986). 
Daily monitoring of urinary HEX excretion is a helpful adjunct method in diagnosis of renal 
damage caused by rejection and ischemia (Sandman et al., 1973), as determination of urinary 
HEX excretion is a reliable, rapid, sensitive and simple method. Excretion of urinary HEX 
may be a sign of impending rejection of kidney transplant, and daily measurement of HEX 
output may be useful in the early diagnosis of rejection (Koivula et al., 1978).  
It is stressed that urinary HEX activities measured and reported every day are essential, if 
an early warning of kidney rejection is to be detected. However, during evaluation of 
increases in urinary HEX activity, causes of increase not connected with rejection 
(gentamycine toxicity, urinary tract infection, septicemia, pancreatitis, cardiac failure and 
thrombosis renal artery or vein) should also be considered (Corbett et al., 1978).  
Increases in serum (Loko et al., 1991), and urinary total HEX activity in renal transplant 
patients (Keyser et al., 1976), caused by HEX intermediate forms, which resemble the 
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increase caused by oral contraceptive steroids, pregnancy, diabetes mellitus and liver 
diseases were reported. Chronic renal failure resulted in a decrease of serum HEX activity. 
In control serums and serum with elevated HEX activity HEX A was the dominant activity. 
Activity of HEX B was low or not detected. An intermediate serum HEX peak was present 
as a minor peak in the control sera, but intermediate forms accounted for about 40% of 
serum HEX activity in the renal transplant group. Urinary HEX provided a sensitive 
indicator of active renal disease (Thompson et al., 1977). Increased urinary HEX preceded 
the increase of serum creatinine, and was therefore the earliest detectable indication of 
rejection. Determinations the urinary HEX available to the clinician on the same day are 
possible without preservation of urine, and they are not subject to bacterial contaminations. 
There is agreement that the determination of HEX in urine will provide a slightly earlier 
results than with other methods, however HEX urinary activities may have a serious 
limitation in cases of bacterial or toxic complications (Keyser et al., 1976; Thompson et al., 
1977). 
During evaluation of HEX and Alanine AminoPeptidase (AAP) activities, Corrected to 
baseline Fractional Excretion (CFE), and in differential diagnosis of Cyclosporine Acute 
Nephrotoxicity (CsAN) or in Acute Rejection (AR) crisis, after renal transplantation, CFE 
values above normal for both HEX and AAP, were more frequently found in episodes of 
acute rejection, than in cyclosporine acute nephrotoxicity episodes (76vs 0%; p<0.001). 
Consequently a rise in CFE levels for both HEX and AAP is strongly suggestive of acute 
rejection crisis (Bornstein et al., 1996). Using a spectrophotometric method for HEX, and 
separation of urinary inhibitors on Sephadex G-25, the CFE normal value for HEX was 
4.26±3.23, and  the abnormal was 10.76 + 2SD. Out of 21 AR episodes, 16 had abnormal CFE 
values for both HEX and AAP, 4 for HEX alone and 1 for AAP alone. Abnormal CFE values 
for both HEX and AAP were more frequently found in AR episodes than in CsAN episodes 
(76 vs 0%; p<0.001). The sensitivity, specificity, positive predictive value and diagnostic 
efficiency in regard to AR and CsAN is 0.84; 0.66; 0.7; 0.73 for HEX alone, and 0.63; 0.95; 
0.93; 0.80, for HEX and AAP, respectively. On the basis of above results it was concluded 
that determination of both enzymes presents a rapid, reliable, cheap, noninvasive and easily 
available method to help assessing the postoperative period of patients undergoing renal 
transplantation (Bornstein et al., 1996). Evaluating HEX and AAP as indicators of graft 
function in renal transplant recipients taking cimetidine, urinary HEX and AAP, excretions 
were found to be normal throughout the period of treatment with cimetidine, which 
indicated that observed continuously high concentrations of creatinine in serum were not 
due to impairment of graft function (Krishna et al., 1986). Therefore urinary activities of 
HEX and AAP may be valuable as complementary renal-function tests in transplant 
recipients receiving cimetidine, in addition to being useful as early markers of rejection 
(Krishna et al., 1986). 
Urinary HEX activity is a valuable indicator of drug nephrotoxicity. Very high and 
overlapping urinary excretion of HEX in about 35% of renal transplant patients treated 
with cyclosporin and prednisolne, or prednisolone with azathioprine, was reported 
(Tataranni et al., 1992). However, in the group of patients affected by autoimmune 
steroid-unsensitive uveitis treated with cyclosporin at progressively decreasing doses, 
urinary HEX activity decreased in parallel to decreasing cyclosporin doses. HEX release to 
the tissue culture medium was used as a specific marker of renal tubular cell injury for in 
vitro evaluation the nephrotoxicity of two immunosuppressive drugs: FK506 and 
cyclosporin A (Moutabarrik et al., 1992). HEX release to the medium from tubular cells 
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incubated with 0.1 and 1 μM FK506, as well as 1 μM cyclosporin A for 10, 24, and 48 hr, 
was not different from that of the control. In contrast to the above statement, 50 μM of 
FK506, and CsA induced a significant release of HEX to the medium from tubular cells 
treated for 10, 24, and 48hr (p<0.01) with these drugs, whereas 10 μM CsA significantly 
increases HEX release only after 48hr incubation. At the same concentrations, CsA seemed 
to induce a greater HEX release than FK506 (p<0.01) (Moutabarrik et al., 1992). 
Gentamicin nephrotoxicity accompanied by increased urinary excretion of HEX and ǃ-
galactosidase, appeared consistently within three days after the start of treatment, and fell 
towards pre-treatment levels a week after stopping the treatment (Wellwood et al., 1978). 
Other antimicrobial agents (ampicillin, ampicillin+cloxacilin, cephalexin, sulphonamides, 
nalidixic acid, nitrofurantoin, tetracycline) did not change urinary HEX excretion. It is 
worth of noting that increase in urinary HEX excretion after gentamicine treatment, 
preceded increase in serum creatinine and urinary proteins. Causes of impairment in 
renal function in patients with renal allografts are often difficult to determine, therefore 
rejection of the graft must always be taken into consideration. Graft nephrectomy in two 
patients and hemodialysis in another two were reported, after gentamycin treatment, and 
it is concluded that increase in urinary HEX should not be interpreted as an indicator of 
rejection of renal allograft when the patient is receiving gentamycin (Wellwood et al., 
1978). During determination of HEX excretion 24 hr before and 24 hr after intravenous 
application of ioxaglate (contrast medium) in renal transplant patients, none of the 
patients receiving ioxaglate, experienced altered urinary HEX excretion, but only a 
tendency to increase, even in patients treated with cyclosporine, and patients with GFR 
<60ml/min. (Deray et al., 1995). The only objection to that results is the short time of 
determination of HEX urinary excretion after application of ioxaglate, as another 
researchers (Wellwood et al., 1978) observed increase in urinary HEX excretion three days 
after administration of gentamycine. However, it was found on the rat model, that 
ioxaglate induced a smaller increase in urinary HEX excretion than diatrizoate sodium 
meglumine (Deray et al., 1990). It was reported that PenToXifylline (PTX) seemed to be 
temporarily effective in reducing proteinuria and stabilizing renal graft function in more 
than half of patients at the end of 6 month follow-up in Chronic Allograft 
Nephropathy(CAN) (Shu et al., 2007). However in CAN, PTX increased urinary HEX 
excretion in the 3rd month of follow-up, but stabilized in the 6th month, although urinary 
HEX excretion was still significantly higher than before PTX treatment. Some researchers 
(Shu et al., 2007) believe that the failure to reduce urinary HEX by PTX implies that renal 
tubular damage is not modified by PTX, which decrease both proteinuria and urinary 
HEX excretion in Type 2 diabetic patients (Navarro et al., 2003). 
6. Stabilization of FBP-1,6 and HEX activities in human urine 
Excretion of enzymes into urine depends on circadian rhythm. The highest urinary excretion 
rates of arylsulphatase A, ǂ-glucosidase, ǃ-galactosidase and ǃ-glucuronidase, during 24 
hour collection, were found betwen 600 – 900 AM, and the lowest between 100 -900 PM. 
Therefore, collection of urine for 3-hours between 600- 900 AM was recommended for 
determination urinary enzymes (Werner et al., 1970). Other authors (Jung et al., 1992) 
recommend 2-hour collection of urine, i.e. between 600-800AM. Kotanko P. and Pfaller W. 
(Kotanko et al., 1997; Pfaller et al., 1994) recommend collection of urine from second 
morning midstream, as an appropriate specimen for analysis of urinary enzymes. The first 
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portion of urine voided after night, should be definitely avoided, as storage of enzymes in 
urine during the night, may cause enzyme denaturation (Maruhn, 1983; Werner et al., 1970). 
Actually, urinary enzymes are commonly determined in urine of the second morning 
midstream collection, and calculated on gram or mole of excreted creatinine in this urine 
(Kotanko et al., 1997). Daily urinary creatinine excretion is stable and depends essentially on 
the muscle mass of the examined person. 
During preparation of urine for analysis, epithelia and blood cells (Jung et al., 1992) should 
be removed by centrifugation in 3000-4500 rev/min by 5-10 min. Low molecular enzyme 
inhibitors e.g urea, should be removed by gel filtration on Sephadex G-25 or dialysis (Jung 
et al., 1992; Maruhn, 1979). Fresh urine stored in room temperature for several hours retain 
activity of the majority of enzymes. Freezing of fresh urine may decrease the activity of 
some enzymes. It was reported that freezing of urine after dialysis or gel filtration on 
Sephadex G-25 did not decrease the activity of the majority of urinary enzymes (Jung et al., 
1992; Maruhn, 1979; Maruhn, 1983).  
FBP-1,6 activity is comparatively stable in fresh urine stored at + 4°C. Therefore for 
preservation and determination of FBP-1,6, we (Kępka et al., 2009) recommend adjusting the 
pH of urine to pH 5.5-7.5, as FBP-1,6 activity decreased by 48% and 95%, respectively, in 
urine stored at pH 4.5, and 8.5. We (Kępka et al., 2009) do not recommend storage of 
unprotected urine, as the activity of FBP-1,6 stored for 6 days at a temperature of +4°C at pH 
4.5 to 8.5, decreased significantly when compared to its initial activity. The pH 5.5-7.5 was 
optimal for determination and preservation the activity of FBP-1,6 in urine at a temperature 
of +4°C for 6 days with addition of protective substances. Positive effect of 2-
mercaptoethanol (a two-fold increase in FBP-1,6 activity, with 2-mercaptoethanol added) 
was observed in the homogenate of the renal cortex (Burch et al., 1978). In our experience, 
the 2-mercaptoethanol (to protect –SH groups) added to urine may be used for successful 
protection of FBP-1,6 activity in urine stored for 7 days at +4°C (Kępka et al., 2009). Also 
adding 2-mercaptoethanol, and sodium azide (to prevent bacterial growth) into urine, had a 
statistically significant positive effect on FBP-1,6 activity during 7 days storage at +4°C. Our 
results suggest that 2-mercaptoethanol may be used for successful protection of FBP-1,6 
activity in urine stored for 7 days at +4°C. We obtained the best protection of FBP-1,6 
activity in urine stored for 7 days with 2-mercaptoethanol and sodium azide. 
Addition of EDTA into urine had a statistically significant positive effect on FBP-1,6 stability 
during 4 days of storage at +4°C, but after storage longer than 5 days, significant decrease in 
FBP-1,6 activity was observed (Kępka et al., 2009). Our results are in agreement with the 
reports of Pfaller et al. (Pfaller et al., 1994) who, after storing urine for not longer than 5 days 
at a temperature of +4°C with the addition of EDTA, did not observed a significant decrease 
in FBP-1,6 activity. 
There is the possibility of determining FBP-1,6 in urine stored with EDTA for 4 days at +4°C, 
because of an insignificant decrease in FBP-1,6 activity (by 4.6%).  
HEX and majority of urinary enzymes were stable at pH 5.5-7.5 (Jung et al., 1983). The 
mean of total HEX activity in urine of normal males and females was 6.8 units (unit= μ 
mol of methylumbelliferone released from the substrate per hour per litre of urine) 
/mmol of creatinine, with CV within- batch of 3% and between-batch of 8%. Storage of 
urine samples at 4°C or at -20°C had little effect on the total HEX activity. Repeated 
analysis after urine storage for 2 weeks at 4°C showed a decrease which was newer 
greater than 5% of the total activity. During continuous flow analysis of urinary HEX 
isoenzymes separated on DEAE cellulose column in normal urine, a large HEX A and 
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smaller HEX B components were always present, usually in the ratio approximately 4:1. 
Slight traces of intermediate components, I1 and I2 were present in some normal urines, 
but contributed less than 2% of total activity. The reproducibility of isoenzyme profiles 
have CV 7.2%, and inclusion of 5% methiolate altered isoenzyme profile by less than 1%. 
Effect of dialysis on the activity of urinary HEX was minimal with CV of 5.6% (Kind, 
1982). HEX is inactivated at urine pH higher than pH 8.0 (Islekel et al., 2007; Jung et al., 
1982; Jung et al., 1983), but HEX- B isozyme is comparatively stable in alkaline urine 
(Islekel et al., 2007). 
Urinary HEX activity is stable in fresh urine at room temperature for up to 3 hours, in temp. 
4°C ≤ 50 days, and at -20°C for one year. HEX activity in crude urine conserved with 30% 
glycerol or ethylene glycol, was maintained for over 1 year in -20°C; in gel filtrate or 
dialyzate for 3 months in 4°C or -20°C (Jung et al., 1992). It was shown that using albumin 
solution for urine dilution is essential for stability of HEX in diluted urine (Sandman et al., 
1973). 
7. Conclusion  
The literature review revealed that urinary FBP-1,6 and HEX are good markers for 
monitoring  kidney to be transplanted, degree of the ischemic damage of kidney from the 
moment of resection to transplantation, as well as condition of the patient and transplanted 
kidney after transplantation. There were reports of cases where enzymuria precedes 
proteinuria and clinical symptoms of rejection. Determination of urinary FBP-1,6 is more 
complicated  than HEX, because it requires more expensive reagents and strict conditions of 
urine handling and storage. FBP-1,6 and HEX present a rapid, reliable, cheap (particularly 
HEX), noninvasive and easily available methods to help assessing the postoperative period 
of patients undergoing renal transplantation. However, during evaluation of increase in 
urinary FBP-1,6 and HEX activities, causes of increase not connected with rejection, should 
also be considered.   
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